Fig. 6: The difference in abundance of short-chain fatty acids (SCFAs) in responders (R) and non-responders (NR) groups and its association with gut microbiota.
From: Gut microbiota and SCFAs improve the treatment efficacy of chemotherapy and immunotherapy in NSCLC
A Z-score of each SCFA in the R and NR groups. B–J The abundance of acetic, isovaleric, valeric, hexanoic, and isobutyric acid between the two groups, among which the levels of total SCFAs, butanoic and propanoic acid were significantly elevated in the R group, compared with the NR groups. K The relationship between each SCFA and gut microbiota. *P < 0.05, **P < 0.01.
